MARCH BIOSCIENCES INC

MARCH BIOSCIENCES INC is a biotech company in Houston, United States, founded in 2024. It has raised $32.4M across 2 rounds, most recently a $28.4M Series A in October 2024.

Transforming Patient Care by Unlocking New Target Spaces

Headquarters
Houston, Texas
Employees
1–10
Founded
2024
Business Model
B2B
Website
march.bio
Total Funding
$32.4M
Last Round
$28.4M Series AOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.

About

March Biosciences is a Houston, Texas clinical-stage cell therapy company focused on developing CAR-T cell therapies for challenging hematological cancers. Its lead asset, MB-105, is a CD5-targeted CAR-T therapy in Phase 2 clinical trials for relapsed/refractory T-cell lymphoma and has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation. The company was launched from Baylor College of Medicine's Center for Cell and Gene Therapy and has raised over $53 million to date.

Summary

It lists 1–10 employees. It has raised $32.4M in total across 2 rounds, most recently a $28.4M Series A round in Oct 2024. Investors include Mission BioCapital, 4BIO Capital and Cancer Focus Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AOct 2024
$28.4M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MARCH BIOSCIENCES INC on Indexed.vc
<a href="https://indexed.vc/companies/march-biosciences-inc"><img src="https://indexed.vc/api/badge/company/march-biosciences-inc" alt="MARCH BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>